RNS Number:5001K
Syngenta AG 
29 April 2003


Media Release - Communique aux Medias - Medienmitteilung

Syngenta holds Annual General Meeting


Basel, Switzerland, 29 April 2003 - At Syngenta's second Annual General Meeting
in Basel, Syngenta AG shareholders approved all the motions proposed by the
Board of Directors. The 758 shareholders represented 29,636'200 voting shares or
26.33% of 112,564,584 total shares issued. The Annual General Meeting approved
the Board's proposal for a dividend payment of CHF 0.85 gross per share.

The Annual General Meeting approved the annual report, the annual financial
statements and the consolidated financial statement for 2002. Peggy Bruzelius,
Peter Doyle, Pierre Landolt and Pedro Reiser were each re-elected to the Board
for a three-year term of office. Ernst & Young AG were appointed as auditors to
Syngenta AG and as group auditors for the financial year 2003.

Heinz Imhof, Chairman of the Board said: "2002 was a successful year for
Syngenta; the company maintained market share and achieved good results." He
added: "Syngenta increased profitability thanks to tight cost management; we
achieved our scheduled cost synergies sooner than anticipated."

Michael Pragnell, Chief Executive Officer, said: "Our performance reinforces my
confidence in Syngenta's strong competitive platform to deliver increased
shareholder value in 2003 and beyond."

Syngenta is a world-leading agribusiness committed to sustainable agriculture
through innovative research and technology. The company is a leader in crop
protection and ranks third in the high-value commercial seeds market. Sales in
2002 were approximately US $6.2 billion. Syngenta employs some 20,000 people in
over 90 countries. Syngenta is listed on the Swiss stock exchange (SYNN) and in
London (SYA), New York (SYT) and Stockholm (SYN). Further information is
available at www.syngenta.com.


Cautionary Statement Regarding Forward-Looking Statements

This document contains forward-looking statements, which can be identified by
terminology such as 'expect', 'would', 'will', 'potential', 'plans', '
prospects', 'estimated', 'aiming', 'on track' and similar expressions. Such
statements may be subject to risks and uncertainties that could cause the actual
results to differ materially from these statements. We refer you to Syngenta's
publicly available filings with the US Securities and Exchange Commission for
information about these and other risks and uncertainties. Syngenta assumes no
obligation to update forward-looking statements to reflect actual results,
changed assumptions or other factors. This document does not constitute, or form
part of, any offer or invitation to sell or issue, or any solicitation of any
offer, to purchase or subscribe for any ordinary shares in Syngenta AG, or
Syngenta ADSs, nor shall it form the basis of, or be relied on in connection
with, any contract therefore.


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END
RAGILFIFSEIAFIV